Renal Cancer - Results from #8880

Serum cell-free DNA in renal cell carcinoma: A diagnostic and prognostic marker - Abstract July 29, 2011

Impact of renal vein invasion and fat invasion in pT3a renal cell carcinoma - Abstract July 28, 2011

Imprint cytology of the chromophobe renal cell carcinoma: Correlation with the histological and ultrastructural features - Abstract July 28, 2011

Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinoma - Abstract July 27, 2011

Should high-dose interleukin-2 still be the preferred treatment for patients with metastatic renal cell cancer? - Abstract July 27, 2011

Oncologic outcomes of partial versus radical nephrectomy for unilateral Wilms Tumor - Abstract July 27, 2011

Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: New evidence - Abstract July 26, 2011

Clear-cell papillary renal cell carcinoma: 24 Cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases - Abstract July 26, 2011

Allogeneic stem cell transplantation for renal cell carcinoma - Abstract July 25, 2011

Systemic therapy for sarcomatoid renal cell carcinoma - Abstract July 25, 2011

Sorafenib for the management of advanced renal cell carcinoma - Abstract July 22, 2011

Tumor enucleation: A safe treatment alternative for renal cell carcinoma - Abstract July 22, 2011

Hydrocele: An atypical presentation of metastatic sarcomatoid renal cell carcinoma - Abstract July 20, 2011

ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of metastatic disease - Abstract July 20, 2011

Identification of the primary tumour with the help of diffusion-weighted MRI in a patient with autosomal dominant polycystic kidney disease and metastatic renal cell carcinoma - Abstract July 19, 2011

Incidental finding of renal masses at unenhanced CT: Prevalence and analysis of features for guiding management - Abstract July 19, 2011

A phase II trial of panobinostat, a histone deacetylase inhibitor, in the treatment of patients with refractory metastatic renal cell carcinoma - Abstract July 18, 2011

Pathologic significance and prognostic value of phosphorylated cortactin expression in patients with sarcomatoid renal cell carcinoma - Abstract July 18, 2011

Vaccination therapy in renal cell carcinoma: Current position and future options in metastatic and localized disease - Abstract July 15, 2011

Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapies - Abstract July 14, 2011

Page 445 of 456